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Abstract
Introduction: The aim of this study, performed in an intensive care unit (ICU) population with a normal serum
creatinine, was to estimate urinary creatinine clearance (CLCR) in a population of polytrauma patients (PT) through
a comparison with a population of non trauma patients (NPT).
Methods: This was a retrospective, observational study in a medical and surgical ICU in a university hospital. A
total of 284 patients were consecutively included. Two different groups were studied: PT (n = 144) and NPT (n =
140). Within the second week after admission to the ICU, renal function was assessed using serum creatinine, 24 h
urinary CLCR .
Results: Among the 106 patients with a CLCR above 120 mL minute
-1 1.73 m
-2, 79 were PT and 27 NPT (P <
0.0001). Only 63 patients had a CLCR below 60 mL minute
-1 1.73 m
-2 with 15 PT and 48 NPT (P < 0.0001). Patients
with CLCR greater than 120 mL minute
-1. 1.73 m
-2 were younger, had a lower SAPS II score and a higher male
ratio as compared to those having CLCR lower than 120 mL minute
-1. 1.73 m
-2. Through a logistic regression
analysis, age and trauma were the only factors independently correlated to CLCR.
Conclusions: In ICU patients with normal serum creatinine, CLCR, is higher in PT than in NPT. The measure of CLCR
should be proposed as routine for PT patients in order to adjust dose regimen, especially for drugs with renal
elimination.
Introduction
Early detection of renal dysfunction in intensive care
unit (ICU) patients is important. Indeed, an increase of
the glomerular filtration rate (GFR) was demonstrated
in some ICU patients populations by using urinary
creatinine clearance (CLCR) as a surrogate marker, and
many of the drugs used in ICU patients need dose
adjustment as a function of GFR [1]. Despite a normal
serum creatinine measurement, a substantial number
of burn patients demonstrated an increase in GFR with
the need for increasing doses of renal elimination
drugs to maintain therapeutic concentrations [1,2]. A
study of our group showed that 42% of burn patients
had a creatinine clearance greater than 120 mL
minute
-1 1.73 m
2 [1]. Also, several studies performed
in a general population of ICU patients suggested a
poor correlation between serum creatinine concentra-
tion and GFR in polytrauma patients (PT) [3-5]. To
the best of our knowledge, no study has specifically
explored this population of PT patients.
The aim of this study, performed in a population of
ICU patients with normal serum creatinine, was to esti-
mate GFR, evaluated by measured CLCR, in a population
of PT patients through a comparison with a population
of non-trauma patients (NPT).
Materials and methods
Patients
This observational study was conducted in the ICU of
Toulouse University hospital during a five-year period
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any medium, provided the original work is properly cited.(November 2002 to December 2007). The study was
performed according to the Declaration of Helsinki. No
change in our current clinical practice (measured creati-
nine clearance monitoring, at least once a week, is a
part of the routine medical care of the patients) and no
randomization was performed. As it was an observa-
tional retrospective study,i na c c o r d a n c ew i t hF r e n c h
law, neither approval of the ethics committee nor
informed consent was required.
Ten days, on average, after admission in ICU, consecu-
tive critically ill patients meeting the inclusion criteria
were included. Inclusion criteria were: patients older
than 18 years, with an arterial catheter, a urinary bladder
catheter, a diuresis over 500 mL d
-1. All patients had a
tracheal tube and were mechanically ventilated. Patients
were hemodynamically stable presenting with a stable
serum creatinine in a normal range (40 to 125 μmol L
-1).
Patients were excluded from the study: if they were
hemodynamically unstable or if they needed a high dose
of catecholamine (norepinephrine > 1 mg h
-1); if they
were recovering from acute kidney injury (AKI) or
developing AKI; if they received histamine-2-receptor
antagonist due to its interference with tubular creatinine
secretion [6]; and if they had a medical history of dia-
betes, of chronic hepatic disease, cirrhosis or ongoing
liver dysfunction with hepatitis [7,8]. Patients treated
with diuretics were also excluded.
Baseline characteristics of patients were recorded at
enrolment in the study and the SAPS II was obtained at
ICU admission. PT patients had an ISS (Injury Severity
Score) > 16. SOFA (Sequential Organ Failure Assess-
ment) score was obtained on the day the urine 24-hour
measure was sampled [9-11].
Urine was sampled over 24 hours to measure urinary
creatinine concentration. Serum creatinine was also
measured during the urine collection period.
The normal limits of CLCR were estimated between 60
and 120 mL minute
-1 1.73 m
-2 [9,12].
Serum creatinine measurement and calibration
Creatinine measurements were performed in the same
laboratory of the University Hospital of Toulouse. Blood
samples were obtained simultaneously with the CLCR
measurement. A modified kinetic Jaffe colorimetric
method was used with a COBAS MIRA (ABX Diagnos-
tics, Montpellier, France) analyzer. A two-point calibra-
tion was applied in each assay.
Before measurement, ultrafiltration of plasma through
a 20 kD cutoff membrane (MPS-1; Amicon, Beverly,
MA, USA) was performed to discard chromogens that
were linked to albumin-like bilirubinemia and other
heavy proteins. In the absence of an international
standard for creatinine assay, the linearity of the mea-
surements was verified by using plasma samples from
normal subjects in which increasing amounts of desic-
cated creatinine hydrochloride (MW 149.6; Sigma Che-
micals, Perth, Australia) had been added. Linear
regression analysis showed that the relationship between
measured and expected creatinine concentrations was
1.0008 ± 0.006 (95% confidence interval, 0.997 to 1.020)
and that the Y-intercept was 0.014 ± 0.013 (95% confi-
dence interval, -0.013 to 0.041). Squared Spearman rank
coefficient of correlation was 0.998. Internal quality con-
trols showed a coefficient of variation of 2.3% during
the period.
Assessment of glomerular filtration rate
Creatinine clearance was measured according to the
formula CL
UC V
SC
CR
R
R
=
×
where urine creatinine
(UCR) and serum creatinine (SCR) were expressed in
μmol L
-1 and V corresponded to the urinary rate (diur-
esis) in mL minute
-1.
At the same time, the GFR was estimated using the
Cockcroft Gault formula [13]CL
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R
=
−×
×
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.
140
08
for men, with age in years and weight in Kg. A correcting
factor of 0.85 was used for women. The derivate formula
proposed by Robert et al. [14] uses the ideal body weight
and serum creatinine concentration corrected to 85 μmol
L
-1 when the actual value is lower than 85 μmol L
-1. Ideal
body weight was determined as 50 kg for men and 45.5
kg for women, plus 2.3 kg for each inch over five feet.
The simplified formula of the Modification of Diet in
Renal Disease index (sMDRD) [15] was also calculated
according to sMDRD = 186.3 × SCR
-1.154 ×a g e
-0.203 ×
(1.212 if black) × (0.742 if female) where serum creati-
nine was expressed in mg dL
-1.
Statistical analysis
Statistical analyses were performed using StatView
®
software version 5.0 (SAS Institute Inc., Cary, NC,
USA). Data are presented as mean ± standard deviation
(SD) or ratio. Normal distribution of data was tested via
Kolmogorov-Smirnov test. Chi-square test or Student’s
t-test was performed when appropriate. A logistic
regression was performed to discriminate if trauma, age,
SAPS II, ideal body weight and sex are independently
correlated to the measured CLCR.AP-value < 0.05 was
considered as statistically significant.
Results
Demographic and renal data are shown in Table 1. Two
hundred, eighty-four patients were consecutively
included in this observational study. The process
of screening and inclusion in the study is shown in
Figure 1 (flow chart).
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Page 2 of 7The group of 144 PT patients was compared with the
group of 140 NPT patients. No difference was found con-
cerning hemodynamic data (Table 1). No difference was
found concerning ventilation pressure. All the patients
were ventilated with a tidal volume of 6 to 8 ml/kg, the
PEP value was set at 5.8 ± 3 in PT vs 5.5 ± 3 in NPT
patients (NS). FiO2 was 45 +/- 16% in PT vs 45 +/- 15 in
N P T( N S ) ,w i t hP h=7 . 3 8+ / -0 . 8v s7 . 3 9+ / -0 . 8( N S ) ,
P a O 2=1 0 7+ / -1 6i nP Tv s1 0 8+ / -1 5i nN P T( N S ) ,
PaCO2 = 39 +/- 8 in PT vs 40 +/- 9, SaO2 = 97 +/- 3 vs
97 +/- 3 (NS). Glycemia was not different between
groups (6.2 +/- 1.7 vs 6.1 +/- 1.8; NS). Twenty-three per-
cent of PT vs 24% of NPT received norepinephrine (NS).
The overall results show that serum creatinine was
normal (73 ± 22 μmol L
-1) and serum urea (8 ± 4 mmol
L
-1) was slightly higher than the normal limits, but with
no difference between groups. One hundred, six patients
had a CLCR above 120 mL minute
-1 1.73 m
-2,i n c l u d i n g
79 PT and 27 NPT (P < 0.0001). Only 63 patients had a
CLCR below 60 mL minute
-1 1.73 m
-2 with 15 PT and
48 NPT (P < 0.0001), whereas nine patients had a CLCR
below 30 mL minute
-1 1.73 m
-2, including two PT.
The overall urinary creatinine excretion was 929 ± 678
mg 24 h
-1 1.73 m
-2 for women and 1,369 ± 685 mg 24
h
-1 1.73 m
-2 for men. There was a significant difference
between the urinary creatinine excretion of PT and
NPT patients (1,489 ± 639 vs 969 ± 688 mg 24 h
-1 1.73
m
-2 respectively, P < 0.001). In the PT group, males had
significantly higher urinary creatinine excretion than
females (1,630 ± 644 vs 1,067 ± 392 mg 24 h
-1 1.73 m
-2,
P < 0.001).
The overall measured CLCR was 108 ± 57 mL minute
-
1 1.73 m
-2.T h eC L CR was higher in PT patients than in
NPT patients when using measured CLCR (131 ± 56 vs
85 ± 48 mL minute
-1 1.73 m
-2 respectively, P < 0.001).
Most patients with increased CLCR (above 120 mL
minute
-1 1.73 m
-2)w e r eP Tp a t i e n t sa ss h o w ni nT a b l e
2. On the opposite, most patients with decreased CLCR
(below 60 mL minute
-1 1.73 m
-2) were NPT patients.
Patients with CLCR greater than 120 mL minute
-1 1.73 m
-2
were younger (40 ± 16 years vs 56 ± 18 years), had a lower
S A P SI Is c o r e( 4 3±1 4v s5 0±1 5 )a n dah i g h e rm a l er a t i oa s
compared with patients presenting a CLCR lower than 120
mL minute.
Table 1 Demographic data
NPT
a (n = 140) PT
b (n = 144) P*
Age (yr) 58 ± 17 42 ± 18 < 0.0001
Weight (kg) 72 ± 18 75 ± 14 NS
Height (cm) 170 ± 8 174 ± 9 NS
Sex (F/M) 52/88 36/108 0.03
Ideal body weight (Kg) 68 ± 11 72 ± 11 0.0006
SAPS 2 52 ± 14 42 ± 15 < 0.0001
Total SOFA score 3.7 ± 1.5 3.6 ± 1.4 NS
Respiratory system 0.3 ± 0.2 0.5 ± 0.6
Coagulation 0.0 ± 0.0 0.0 ± 0.0
Liver 0.0 ± 0.0 0.0 ± 0.0
Cardiovascular system 1.3 ± 0.9 1.4 ± 0.9
Neurological system 2.5 ± 1.5 2.4 ± 1.5
Renal system 0.0 ± 0.0 0.0 ± 0.0
Mean arterial blood pressure (mmHg) 83 +/- 10 82 +/- 11 NS
Systolic arterial blood pressure (mmHg) 126 +/- 16 125 +/- 17 NS
Diastolic arterial blood pressure (mmHg) 63 +/- 10 63 +/- 11 NS
Heart rate (bpm) 91 +/- 17 92 +/- 16 NS
Serum creatinine (μmol L-1) 74 ± 26 72 ± 19 NS
Measured creatinine clearance (mL minute
-1 1.73 m-2) 85 ± 5 131 ± 5 < 0.0001
Diuresis/24H 2,700 ± 1,200 2,500 ± 1,200 NS
Serum Urea 8.7 ± 5 7 ± 3 NS
Measured creatinine clearance < 60 (mL minute
-1 1.73 m-2) 48 15 0.0003
Measured creatinine clearance > 120 (mL minute
-1 .1.73 m-2) 27 79 < 0.0001
All data are expressed as ratio or mean ± SD.
*The P-values correspond to comparison between NPT and PT groups.
aNPT, non-polytrauma patients.
bPT, polytrauma patients.
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Page 3 of 7All factors presenting a statistical difference between
hyperfiltration and hypofiltration subgroups (Table 2) were
analyzed. Through a logistic regression analysis, including
goodness of fit of the model, age and trauma were the only
factors independently correlated to CLCR (Table 3).
Discussion
The present results comparing a population of hemody-
namic stable PT patients to a population of hemody-
namic stable NPT patients with steady state serum
creatinine concentration with a normal creatinine serum
value demonstrate that (i) PT patients exhibit dramatic
variations of their CrCl; (ii) CrCl is higher in PT
patients than in NPT patients; (iii) Age and trauma are
independently correlated factors to CLCR in our study
and in these study conditions.
Considering serum creatinine values, no significant dif-
ference was found between PT and NPT groups despite
the variations of CrCl. These data demonstrated that a
wide range of measured CLCR variations exists and,
therefore, confirm Hoste data obtained in critically ill
patients with serum creatinine within normal range [16].
These authors demonstrated that “serum creatinine has a
low sensitivity for detection of renal dysfunction”.O u r
results also revealed some opposite trends between CrCl
and creatinine measurements, as some patients had
significantly lower values of serum creatinine for CLCR >
60 mL minute
-1 1.73 m
-2 than for CLCR < 60 mL minute
-
1 1.73 m
-2. These data underline the inaccuracy of serum
creatinine values in estimating the renal function.
Fifty-five percent of PT patients, and only 19% of NPT
patients presented a measured CLCR above 120 mL min-
ute
-1 1.73 m
-2. In addition, only 10% of PT patients vs 34%
of NPT patients presented a measured CLCR below 60 mL
minute
-1 1.73 m
-2. In clinical practice, the diagnosis of
increased CLCR as a surrogate marker of GFR is important
and has largely been demonstrated in burn patients in the
setting of antibiotics monitoring: ceftazidime, cefepime,
vancomycin and amikacin [4,5,17,18]. In critically ill
patients, high CLCR required high doses of drugs, which
are eliminated by the kidneys to obtain therapeutic con-
centration. Recently we confirmed the need for CLCR
monitoring in order to accurately monitor renal function
and, therefore, to optimize the doses of antibiotics [4,19].
Our results demonstrate that age, gender, ideal body
weight, severity index, trauma patients, and serum creati-
nine are factors for a CLCR above normal (> 120 mL min-
ute
-1 1.73 m
-2), and for a moderate renal impairment
(CLCR <6 0m Lm i n u t e
-1 1.73 m
-2). Through a logistic
regression analysis, only two factors (age and trauma
patients) remained significantly correlated with a CLCR
above normal and for a moderate renal impairment. In the
Figure 1 Flow chart showing the process of recruitment.
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Page 4 of 7current results, 12% of elderly patients (over 65 years) have
aC L CR greater than 120 mL minute
-1 1.73 m
-2.T h e
impact of age on CLCR is well known and this parameter
was, therefore, introduced in the formulas estimating
CLCR (Cockcroft-Gault, Robert and simplified MDRD)
[13-15]. The decrease in glomerular filtration, the involu-
tion of nephronic units and the reduction of the renal
blood flow explain the high frequency of renal impaire-
ment in elderly patients. However, it should be kept in
mind that glomerular ageing is correlated to age in only
two-thirds of the patients, and this phenomenon accounts
for the inaccuracy of the CLCR estimated by calculated for-
mulae [20].
Current evidence suggests that PT (mainly, young
patients without significant comorbidities) present with a
CLCR increase. However, this phenomenon as received
little attention in the literature, and dose modification are
therefore rarely considered. The present results clearly
demonstrate for the first time that trauma is a major fac-
tor for CLCR increase. Several factors may explain this
increase in CLCR in PT patients. First, urinary creatinine
excretion may be involved in such a phenomenon. A
higher creatinine urinary excretion was observed in PT
compared with NPT patients whereas serum creatinine
was similar in both groups. However, the higher creati-
nine urinary excretion observed in PT patients was
within a normal range. Serum protein variations may
impact our results. However, all the patients had a serum
protein value between 50 and 55 gL
-1. It is, therefore,
very unlikely that serum protein variations interfere with
the present results. Also, regarding hemodynamics, CLCR
were studied and measured at a steady state in both
groups (that is, distant from the admittance). It should be
noted that our patients were hemodynamically stable at
the time of data collection with no sign of dehydration.
Although interference due to some cephalosporin has
been described when the creatininemia was measured by
using the Jaffe method [21]; no changes in this parameter
were observed during the overall period of the study.
Sepsis can also reduce creatinine production as described
in mice [22]. Moreover, in critically-ill patients, a positive
Table 2 Comparison of patients with different measured creatinine clearance (CLCR)
ClCR < 120
(n = 178)
ClCR > 120
(n = 106)
P*C l CR <6 0
(n = 63)
ClCR >6 0
(n = 221)
P
# P§
Age (yr) 56 ± 18 40 ± 16 <0.0001 63 ± 15 46 ± 18 <0.0001 <0.0001
Weight (Kg) 74 ± 17 74 ± 14 NS 73 ± 19 74 ± 15 NS NS
Sex (F/M) 64/114 24/82 0.03 35/28 161/60 NS 0.0032
Ideal body weight (Kg) 69 ± 12 72 ± 10 0.01 65 ± 11 71 ± 11 0.0002 <0.0001
SAPS 2 50 ± 15 43 ± 14 0.0002 54 ± 14 45 ± 15 <0.0001 <0.0001
Serum creatinine (μmol L
-1) 76 ± 24 67 ± 19 0.0001 85 ± 25 69 ± 20 <0.0001 <0.0001
Diuresis/24H 2,400 ± 100 2,800 ± 1200 <0.0001 584 ± 224 1,418 ± 694 <0.0001
Measured creatinine clearance (mL min
-1 .1.73 m
-2) 74 ± 30 166 ± 50 <0.0001 43 ± 11 127 ± 50 <0.0001 <0.0001
Simplified MDRD (mL minute
-1 1.73 m
-2) 96 ± 39 119 ± 45 <0.0001 81 ± 34 112 ± 43 <0.0001 <0.0001
Cockcroft-Gault (mL minute
-1 1.73 m
-2) 98 ± 39 130 ± 34 0.0005 80 ± 39 118 ± 36 <0.0001 <0.0001
Robert (mL minute
-1 1.73 m
-2) 72 ± 23 94 ± 23 <0.0001 59 ± 2 85 ± 2 <0.0001 <0.0001
PT
b/NPT
a 65/113 79/27 <0.0001 15/48 129/92 <0.0001 <0.0001
All data are expressed as ratio or mean ± SD.
*The P-values correspond to comparison between subgroup with CLCR greater than 120 mL minute
-1 1.73 m
-2 versus subgroup with CLCR lower than 120 mL
minute
-1 1.73 m
-2.
#The P-values correspond to comparaison between subgroup with CLCR greater than 60 mL minute
-1 1.73 m
-2 versus subgroup with CLCR lower than 60 mL
minute
-1 1.73 m
-2.
§The P-values correspond to comparison between less than 60 mL minute
-1 1.73 m
-2 more than 120 mL minute
-1 1.73 m
-2.
aNPT = non-polytrauma patients.
bPT = polytrauma patients.
Table 3 Logistic regression for different measured
creatinine clearance
P* Odd ratio (CI 95%)
CLCR > 120 mL minute
-1 1.73 m
-2
Age < 0.0001 0.95 (0.93 to 0.97)
SAPS 2 0.56 1.00 (0.98 to 1.04)
Ideal body weight 0.29 0.97 (0.93 to 1.02)
Gender 0.564 0.41 (0.12 to 1.4)
PT 0.0001 3.33 (1.8 to 6)
CLCR < 60 mL minute
-1 1.73 m
-2
Age < 0.0001 0.95 (0.93 to 0.97)
SAPS 2 0.36 0.98 (0.95 to 1.02)
Ideal body weight 0.3 1.03 (0.97 to 1.09)
Gender 0.8 0.84 (0.97 to 1.09)
NPT 0.02 2.39 (1.15 to 4.97)
PT = polytrauma patients, NPT non polytrauma patients.
* The P-values correspond to logistic regression with CLCR greater than 120
mL minute
-11.73 m
-2 (C index = 0.56).
# The P-values correspond to logistic regression with CLCR lower than 60 mL
minute
-1 1.73 m
-2
(C index = 0.58).
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Page 5 of 7fluid balance may lead to underestimation of the severity
of AKI and delay the recognition of a 50% relative
increase in sCr [23]. Finally, it should be hypothesized
that humoral and inflammatory mechanisms encountered
after severe trauma [24] or burn [1] are involved in the
observed CLCR increase.
The present study encountered some limitations.
Increased CLCR is related with enhanced renal elimina-
tion of circulating drugs. However, describing this phe-
nomenon in terms of current available measures of the
GFR at the bedside is still debated. In our study, the GFR
was estimated by measured creatinine clearance on a 24-
hour urine collection. However, the gold standard for
GFR assessment is the measure of inuline clearance [25]
but the cost and complexity of this tool limits its applica-
tion in routine. Another limitation is the lack of consen-
sus regarding the upper limit of normal GFR. However,
increasing data support the concept of increased GFR in
PT patients, and several reports demonstrated subthera-
peutic concentrations of drugs in PT patients [5,26].
Also, a cross-sectional single 24-hr measure of CLCR at
10 days in relatively stable patients was performed but
fast modifications of kidney function may occur and
there is a need for a continuous re-evaluation. Finally,
some other factors may influence our results. In particu-
lar, fluid status, cardiac output may be significantly
altered from baseline. However, whatever the causes of
these alterations, the ATLS (Advanced Trauma Life sup-
port) principles are applied in our institution regarding
resuscitation of PT patients. We, therefore, believe that
the current results are broadly representative of the
population of PT patients. It could be argued that the
external validity of this single-center study may be lim-
ited. However, our findings may be relevant to the vast
majority of level I trauma centers, provided that ATLS
principles are applied in these institutions.
Conclusions
In hemodynamic ICU stable patients with steady state
serum creatinine concentration, CLCR, which is a surro-
gate marker of GFR, is higher in polytrauma patients
than in other critically ill patients. In ICU patients, the
drug monitoring must take into account the glomerular
filtration rate. The measure of CLCR should be routinely
proposed for PT patients in order to adjust dose regi-
men, especially for drugs with renal elimination (beta-
lactams, ceftazidime, cefepime, piperacillin, vancomycin,
aminoglycosides, and so on).
Key messages
￿ In ICU patients with normal serum creatinine,
CLCR,i sh i g h e ri nt r a u m at h a ni nn o n - t r a u m a
patients.
￿ The measure of CLCR should be proposed in rou-
tine for ICU patients in order to adjust dose regi-
men, especially for drugs with renal elimination.
￿ Age and trauma were the only factors indepen-
dently correlated to CLCR.
￿ Glomerular filtration rate should be measured in
ICU patient to detect renal filtration abnormalities.
￿ Serum creatinine is not a good marker for renal
function estimation.
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